SCHEMBL5459215

SCHEMBL5459215

COc1ccc(C)cc1NC(=O)Nc1ccc(N2CCN(C(=O)Nc3ccc(CO)cc3Cl)CC2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RBP4 P02753 2/20 0.52
MAPT P10636 9/20 0.48
TP53 P04637 4/20 0.48
MEN1 O00255 3/20 0.48
KMT2A Q03164 3/20 0.48
GAA P10253 1/20 0.48
MAPK1 P28482 1/20 0.48
LMNA P02545 6/20 0.48
SMN1; SMN2 Q16637 3/20 0.48
HPGD P15428 1/20 0.48
POLB P06746 1/20 0.48
THRB P10828 1/20 0.47
RAB9A P51151 2/20 0.47
HTT P42858 1/20 0.47
ALDH1A1 P00352 3/20 0.47
NPSR1 Q6W5P4 1/20 0.47
NPC1 O15118 1/20 0.46
HTR1A P08908 1/20 0.46
HTR1D P28221 1/20 0.46
HTR1B P28222 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5451462 0.92 MAPT (0.50) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5453431 0.89 RBP4 (0.54) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5467407 0.87 RBP4 (0.52) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5456806 0.87 RBP4 (0.55) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5460156 0.87 MAPT (0.51) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5462762 0.86 RBP4 (0.51) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5469366 0.85 MAPT (0.48) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5467503 0.84 MAPT (0.48) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5462428 0.84 RBP4 (0.50) RBP4MAPTTP53MEN1KMT2A
SCHEMBL5459775 0.82 MAPT (0.51) RBP4MAPTTP53MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 RBP4 2001/4885MAPT 758/4885TP53 3723/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.